During the double-blind withdrawal period, 41.9% of ecopipam-treated patients relapsed compared with 68.1% of placebo-treated patients. Topline data were announced from a phase 3 trial evaluating ...
Morning Overview on MSN
Study: Acetylcholine timing shapes dopamine’s role in brain circuits
A growing body of mouse and rat research is rewriting the textbook on how dopamine, the brain’s primary reward signal, ...
Migraines are a leading cause of disability. Worldwide about 14.7 percent of people experience migraines. Migraines entail severe pain as well as increased sensitivity to usually non-painful stimuli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results